Aledort L M
Mount Sinai School of Medicine, New York, NY, USA.
Thromb Haemost. 1997 Jul;78(1):562-5.
Von Willebrand's disease was recognized by a careful observant clinician. Research advances in blood banking technology and molecular biology, in addition to astute clinical observation, have led to unraveling the factor VIII molecule, classification of a heterogenous disease, and rational therapy.